The 22nd Annual Winter Lung Cancer Conference, January 31-February 2, 2025, will cover advances in NSCLC and SCLC treatment.

Virologist treats breast cancer with oncolytic virotherapy, shrinking the tumor and boosting immune response. An ...

Neoadjuvant chemotherapy for advanced ovarian cancer was initially administered as an alternative treatment for patients not suitable for primary debulking surgery (PDS) because of unresectable ...

在她的坚持下，这篇论文最终在Vaccines期刊发表，论文题为：An Unconventional Case Study of Neoadjuvant Oncolytic Virotherapy for Recurrent Breast Cancer ...

Dongan Hills resident Melissa Hickey turned her chemotherapy sessions into carnivals, movie sets and tea parties.

Atossa Therapeutics has strong financials with $79.5 million in cash and a cash runway of 13-14 quarters, minimizing ...

Nurse navigators and APPs are key members of the multidisciplinary team who can lead and implement QI efforts to ensure ...

Perioperative chemoimmunotherapy for resectable non-small cell lung cancer (NSCLC) shows promising long-term benefits with ...

Impact and progress Frontiers' impact Progress Report 2022 All progress reports ...

IMNN-001 immunotherapy plus standard-of-care chemotherapy resulted in 35% improvement in overall survival and 25% improvement in progression-free ...